Biotech Innovation Technology 
TechCrunch
JULY 16, 2021
John Flavin is founder and CEO of Portal Innovations, LLC. 2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 billion invested across 1,073 deals — the market for new innovations remains strong.
TechCrunch
DECEMBER 15, 2022
That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.
Crunchbase News
DECEMBER 3, 2024
Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.
TechCrunch
OCTOBER 28, 2022
Omar Khalil is a partner at Santé Ventures , where he focuses primarily on biotechnology and medical technology companies. Capital is the fuel that advances scientific and technological innovation, and it means a life science startup can create products that benefit the world at large. Omar Khalil. Contributor. Share on Twitter.
N2Growth Blog
OCTOBER 23, 2023
With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.
TechCrunch
AUGUST 18, 2022
The hearing loss market has long been dominated by a handful of legacy players with little incentive to innovate due to outdated regulations and social stigma. On Monday, the FDA announced that hearing aids and other hearing technology can now be sold over the counter. But a new ruling from the U.S.
Crunchbase News
JANUARY 10, 2025
By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Is there a business model to support the technology?
Expert insights. Personalized for you.
240 
Let's personalize your content